NYSE · Medical - Healthcare Information Services
EVH (EVH) Stock
$3.04
-4.56%
NYSE: EVH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
Zacks · Jul 14, 2026
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
PR Newswire · Jul 8, 2026
Should You Buy Evolent Health (EVH) After Golden Cross?
Zacks · Jul 3, 2026
Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind
MT Newswires · Jun 30, 2026
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Zacks · Jun 29, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About EVH
EVH is led by CEO Seth Barrie Blackley, employs 4,500 people, headquartered in US, publicly traded since 2015.
EVH stock trades at $3.04 with a market capitalization of $341.38M. The stock is valued at a price-to-earnings (P/E) ratio of -0.77, price-to-book of 1.06, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $2.10 and $12.06, and currently trades 74.8% below its 52-week high.
On profitability, EVH generates a return on equity (ROE) of -128.92%, return on capital employed of -0.96%, an operating margin of -0.21%, a net profit margin of -26.29%.